Here we for the first time demonstrated that MIIP inhibits prostate cancer cell proliferation by interacting with PP1α and facilitating PP1α-dependent dephosphorylation of AKT and attenuation of downstream AKT-mTOR signaling pathway. Here, AKT1 is linked to prostate cancer.